跳至主要内容
临床试验/ACTRN12608000152325
ACTRN12608000152325招募中未知

Patients with known or suspected liver disease who are indicated for laparoscopic liver biopsy undergo near infrared confocal imaging, to assess the feasibility and diagnostic potential of in vivo confocal images compared with conventional histopathological analysis of liver biopsy tissue.

Optiscan Pty Ltd0 个研究点目标入组 20 人开始时间: 2008年3月31日最近更新:

试验速览

阶段
未知
状态
招募中
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Diagnosis
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Patients indicated for laparoscopic liver assessment as determined by the attending hepatologist, age >18 years, a negative pregnancy test, written informed consent.

排除标准

  • Patients under the age of 18 years.
  • Patients with blood coagulation disorders (Quick's test <50%; PTT>50s; platelets <50.000/nl), impaired renal function (serum creatinine >1.2mg/dl), lack of liver visualisation by ultrasonography, uncontrolled ascites or hyperthyreosis.
  • Patients unable to give informed consent. Women who are pregnant or breast-feeding.
  • Patients with known allergy or prior adverse reaction to Indocyanine Green.

研究者

相似试验